CLINICAL CHEMISTRY.

Yves Laure Pimentel · 70問 · 2年前

通報

問題一覧

Sweat test in cystic fibrosis High in what electrolytes

Na* and Cl

substance that can yield a hydrogen ion

Acid

mmhg , The normal difference between alveolar and arterial PO2 (PAO2—PaO2 difference)

10 mmHg

RATIO? of HCO; to H2CO; (total dissolved carbon dioxide)

20:1

represents the combined hydration and dissociation constants for CO2 in blood at 37°C

6.1

formula: Getting dissolved carbon dioxide (dCO,)

pCO2 x 0.03

associated with both metabolic and respiratory alkalosis

Hypokalemia

only anticoagulant that does not alter the pH of blood

Heparin

anticoagulant Open heart surgery

Heparin

anticoagulant For cardiopulmonary bypass

Heparin

Storage time for ABG should be no more than

30 min

exposure of a normal arterial blood sample to room air PO2 ?, PCO2 ?>, pH ?

PO2 increased PCO2 decreased pH increased

how many pH decrease/each Celsius above 37°C

.015

Inhibit GH secretion (6)

BI GATE B-agonist (epinephrine) Insulin def Glucose loading a-blockers (phentolamine) Thyroxine def Emotional/Psychogenic stress

Gold standard for GH deficiency

Insulin Tolerance Test

Confirmatory for acromegaly

GLUCOSE SUPPRESSION TEST (OGTT 100g glucose)

Not a hormone-producing-gland

Posterior pituitary gland

Secretes Oxytocin and ADH

Posterior pituitary gland

Milk ejection and uterine contraction

Oxytocin

Water retention

ADH

Low ADH/ADH resistant — Diabetes insipidus

ADH

High ADH — SIADH

ADH

Thyroid location

Lower anterior neck

Majority of T4 is bound to

TBG —a globulin

Most potent Thyroid hormone

Predominant Thyroid hormone

Test used to Differentiate Primary from secondary Hypothyroidism

TSH Test

If a screening TSH is high, which test is likely to be ordered next?

FT4

the most reliable indicator of thyroid status in sick individuals

FT4

Increase protein will

increase TBG

Antithyroglobulin autoantibodies — interference . what assay?

TG- Thyroglobulin assay

Not a part of thyroid function test

TG assay

the MOST POTENT mineral corticoid (electro-regulating hormone)

Aldosterone

this Increase in BP and BV (Blood volume) suppresses secretion of renin

Aldosterone

Confirmatory test for Conn/primary hyperaldosteronism

Saline suppression test

specimen: The most sensitive and specific screening test for excess cortisol prod using HPLC or GC-MS

24 hr urine free cortisol

MOST WIDELY USED salivary cortisol test

Overnight/rapid dexamethasone suppression test

The most sensitive and specific screening test for excess cortisol prod

Low Dose dexamethasone Suppression test

spx MOST WIDELY USED salivary cortisol test

Midnight plasma cortisol

GOLD STANDARD for secondary and tertiary hypocortisolism

Insulin Tolerance Test (ITT)

First responders to stress

Cathecholamines

Major metabolite of epinephrine

VMA

Major metabolite of Dopamine

HVA

has poor sensitivity and specificity (least helpful) in the diagnosis of pheochromocytoma

Urinary VMA

Urinary VMA has poor sensitivity and specificity (least helpful) in the diagnosis of

pheochromocytoma

Cardioprotective > assoc to CVD

Estrogens

Present in both male and female

Estradiol (E2)

SINGLE BEST HORMONE to determine whether OVULATION HAS OCCURRED

Progesterone

causes infertility

Stress

Stress causes

infertility

diagnostic marker for Zollinger-Ellison Syndrome

Gastrin

Gastrin diagnostic marker for

Zollinger-Ellison Syndrome

Diagnostic marker for Carcinoid syndrome. (Argentaffinoma)

5HIAA

5HIAA Diagnostic marker for

Carcinoid syndrome. (Argentaffinoma)

Vitamin K (phylloquinone )deficiency

Hemorrhage

? deficiency Hemorrhage

Vitamin K (phylloquinone )deficiency

Vitamin B6 deficiency

Facial seborrhea

deficiency Facial seborrhea

Vitamin B6 deficiency

Vit C deficiency

Scurvy

deficiency Scurvy

Vit C deficiency

it is the highest concentration of a drug obtained in the dosing interval

Peak concentration

the lowest concentration of a drug obtained in the dosing interval

Trough Concentration

is the specimen of choice for the determination of circulating concentrations of most drugs

Serum or plasma

SPX is suitable for most drug analysis

Heparinized plasma

Anticoagulant of Choice for TDM

Sodium fluoride

the release of drug

Liberation

transport of drug to the blood

.Absorption

delivery of drug to the tissues ($.2019)

Distribution

what do you call the chemical modification of drug by cells

Metabolism

limination of drug or its metabolite

Excretion

Treatment for Congestive heart failure

Digoxin

are Nephrotoxic and ototoxic

Aminoglycosides

Red man syndrome

Vancomycin

Drug most often implicated in acquired aplastic anemia

Chloramphenicol

for grand mal seizures

Carbamazepine (Tegretol)

Drug of Choice for controlling Petit mal

Ethosuximide (Zarontin)

treatment of manic-depressive illness (bipolar disorder)

Lithium

Antiasthmatic

Theophylline Theobromine

Theophylline Theobromine IS FOR?

Anti asthmatic

Analgesics EXAMPLES

ISAAAT Ibuprofen Salicylates/Aspirin/ acetylsalicylic acid Acetaminophen (Tylenol)

antibiotic which Inhibit cyclooxygenase

Aspirin

antibiotic Assoc to Reye’s syndrome

Aspirin

Most trace elements are of medical importance because excessive levels lead to

toxicity

Trace no known biological purpose

ME THA L CA A MErcury, THAllium, Lead, CAdmium, and Aluminum

elements that Has known biologic purpose

Arsenic zinc, and copper

- necessary for normal methionine metabolism selenium, (m.23)

Arsenic

as the detector - reference method for quantitative identification of most organic compounds

gas chromatography coupled with a mass spectrometer (GC-MS)

is formed when yeast ferments sugar

Alcohol

Most common abused drug

Ethanol

ratio of >2 is highly specific for ethanol-related liver disease

AST/ALT

AST/ALT —a ratio of >2 is highly specific for ethanol-related to what dse?

liver disease

Stages of Acute Alcoholic Influence/Intoxication Blood alcohol concentration (g/100mL) "0.01-0.05 " Stage of Alcohol Influence ?

Subclinical

Stages of Acute Alcoholic Influence/Intoxication Blood alcohol concentration (g/100mL) "0.03-0.12 " Stage of Alcohol Influence ?

Euphoria

Stages of Acute Alcoholic Influence/Intoxication Blood alcohol concentration (g/100mL) "0.09-0.25 " Stage of Alcohol Influence ?

Excitement

Stages of Acute Alcoholic Influence/Intoxication Blood alcohol concentration (g/100mL) "0.18-0.30 " Stage of Alcohol Influence ?

Confusion

Stages of Acute Alcoholic Influence/Intoxication Blood alcohol concentration (g/100mL) "0.25-0.40 " Stage of Alcohol Influence ?

Stupor

Stages of Acute Alcoholic Influence/Intoxication Blood alcohol concentration (g/100mL) "0.35-0.50 " Stage of Alcohol Influence ?

Coma

Stages of Acute Alcoholic Influence/Intoxication Blood alcohol concentration (g/100mL) "0.45+ " Stage of Alcohol Influence ?

Death

Stages of Acute Alcoholic Influence/Intoxication Blood alcohol concentration (g/100mL) ? Stage of Alcohol Influence "Subclinical "

0.01-0.05

100

Stages of Acute Alcoholic Influence/Intoxication Blood alcohol concentration (g/100mL) ? Stage of Alcohol Influence "Euphoria "

0.03-0.12

other names parasitology

other names parasitology

70問 • 2年前

Yves Laure Pimentel · 111問 · 2年前

PARASITOLOGY

PARASITOLOGY

111問 • 2年前

Yves Laure Pimentel · 64問 · 2年前

HTMLBE

HTMLBE

64問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

61問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

HISTOPATHOLOGY

HISTOPATHOLOGY

69問 • 2年前

CC-2 SPECTROPHOTOMETRY

CC-2 SPECTROPHOTOMETRY

Yves Laure Pimentel · 41問 · 2年前

CC-3 ELECTROPHORESIS

CC-3 ELECTROPHORESIS

41問 • 2年前

Yves Laure Pimentel · 87問 · 2年前

AUBF LAB SAFETY

AUBF LAB SAFETY

87問 • 2年前

CSF 1

CSF 1

Yves Laure Pimentel · 82問 · 2年前

CSF 2

CSF 2

82問 • 2年前

SEMEN 1

SEMEN 1

Yves Laure Pimentel · 7問 · 2年前

SEMEN 2

SEMEN 2

7問 • 2年前

SYNOVIAL FLUID 1

SYNOVIAL FLUID 1

Yves Laure Pimentel · 6問 · 2年前

SYNOVIAL FLUID 2

SYNOVIAL FLUID 2

6問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

SEROUS FLUID

SEROUS FLUID

25問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

PLEURAL FLUID

PLEURAL FLUID

44問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

PERICARDIAL FLUID

PERICARDIAL FLUID

18問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

PERITONEAL FLUID/ ASCITIC FLUID

PERITONEAL FLUID/ ASCITIC FLUID

30問 • 2年前

Yves Laure Pimentel · 92問 · 2年前

AMNIOTIC FLUID

AMNIOTIC FLUID

92問 • 2年前

Yves Laure Pimentel · 80問 · 2年前

FECALYSIS

FECALYSIS

80問 • 2年前

Yves Laure Pimentel · 89問 · 2年前

OTHER BODY FLUIDS

OTHER BODY FLUIDS

89問 • 2年前

Yves Laure Pimentel · 86問 · 2年前

MTLBE- SUHO NOTES

MTLBE- SUHO NOTES

86問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

MTLBE..

MTLBE..

35問 • 2年前

Yves Laure Pimentel · 19問 · 1年前

CC- CHROMATOGRAPHY

CC- CHROMATOGRAPHY

19問 • 1年前

Yves Laure Pimentel · 14問 · 1年前

CC-OSMOMETRY

CC-OSMOMETRY

14問 • 1年前

Yves Laure Pimentel · 43問 · 1年前

CC-ELECTROCHEMISTRY TECHNIQUES

CC-ELECTROCHEMISTRY TECHNIQUES

43問 • 1年前

Yves Laure Pimentel · 49問 · 2年前

CC- CARBOHYDRATES

CC- CARBOHYDRATES

49問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

CC- DIABETES MELLITUS

CC- DIABETES MELLITUS

97問 • 2年前

Yves Laure Pimentel · 57問 · 2年前

MAJOR LIPOPROTEINS

MAJOR LIPOPROTEINS

57問 • 2年前

Yves Laure Pimentel · 63問 · 2年前

MINOR LIPOPROTEINS

MINOR LIPOPROTEINS

63問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PROTEINS

PROTEINS

37問 • 2年前

Yves Laure Pimentel · 91問 · 2年前

PLASMA PROTEINS 1

PLASMA PROTEINS 1

91問 • 2年前

Yves Laure Pimentel · 98問 · 2年前

PLASMA PROTEINS 2 (ALPHA 2 REGION)

PLASMA PROTEINS 2 (ALPHA 2 REGION)

98問 • 2年前

Yves Laure Pimentel · 61問 · 2年前

MISCELLANEOUS PROTEINS

MISCELLANEOUS PROTEINS

61問 • 2年前

Liver Function Test 1

Liver Function Test 1

Yves Laure Pimentel · 96問 · 2年前

Liver Function Test 2

Liver Function Test 2

96問 • 2年前

Yves Laure Pimentel · 33問 · 2年前

TUMOR MARKERS

TUMOR MARKERS

33問 • 2年前

Yves Laure Pimentel · 41問 · 2年前

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

KIDNEY FUNCTION TESTS - NON PROTEIN NITROGEN & CREATININE

41問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

GLYCOGEN STORAGE DISEASES

GLYCOGEN STORAGE DISEASES

17問 • 2年前

Yves Laure Pimentel · 14問 · 2年前

LIPID STORAGE DISEASES

LIPID STORAGE DISEASES

14問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

PROTEINS

PROTEINS

71問 • 2年前

Yves Laure Pimentel · 7問 · 2年前

QUICK FIRE- ELECTRODES

QUICK FIRE- ELECTRODES

7問 • 2年前

Yves Laure Pimentel · 10問 · 2年前

ELECTROLYTES

ELECTROLYTES

10問 • 2年前

Yves Laure Pimentel · 27問 · 2年前

DRUGS

DRUGS

27問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

TOXIC AGENTS:

TOXIC AGENTS:

12問 • 2年前

HEMATOLOGY 1 (HEMATOPOIESIS 1)

HEMATOLOGY 1 (HEMATOPOIESIS 1)

Yves Laure Pimentel · 29問 · 2年前

HEMATOLOGY (HEMATOPOIESIS 2)

HEMATOLOGY (HEMATOPOIESIS 2)

29問 • 2年前

Yves Laure Pimentel · 25問 · 2年前

hema diseases

hema diseases

25問 • 2年前

Yves Laure Pimentel · 43問 · 2年前

AML

AML

43問 • 2年前

Yves Laure Pimentel · 71問 · 2年前

GLOBIN SYNTHESIS

GLOBIN SYNTHESIS

71問 • 2年前

Yves Laure Pimentel · 31問 · 2年前

HEMATOLOGY REFERENCE RANGES

HEMATOLOGY REFERENCE RANGES

31問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

DISORDERS OF PRIMARY HEMOSTASIS

DISORDERS OF PRIMARY HEMOSTASIS

34問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

PLATELET DISORDERS

PLATELET DISORDERS

37問 • 2年前

CHARACTERISTICS OF CLOTTING FACTORS

CHARACTERISTICS OF CLOTTING FACTORS

Yves Laure Pimentel · 12問 · 2年前

4. CLASSIFICATION OF MACROPHAGE

4. CLASSIFICATION OF MACROPHAGE

12問 • 2年前

Yves Laure Pimentel · 39問 · 2年前

3. NATURAL OR INNATE IMMUNITY

3. NATURAL OR INNATE IMMUNITY

39問 • 2年前

Yves Laure Pimentel · 55問 · 2年前

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

5. INTERNAL DEFENSE:SOLUBLE FACTORS (ACUTE PHASE REACTANTS)

55問 • 2年前

Yves Laure Pimentel · 37問 · 2年前

6. PHAGOCYTOSIS Chemotaxis

6. PHAGOCYTOSIS Chemotaxis

37問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

8. NATURE OF ANTIGEN

8. NATURE OF ANTIGEN

44問 • 2年前

Yves Laure Pimentel · 50問 · 2年前

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

9. MAJOR HISTOCOMPATIBILITY COMPLEX/HUMAN LEUKOCYTE ANTIGEN

50問 • 2年前

Yves Laure Pimentel · 69問 · 2年前

1. HISTORY

1. HISTORY

69問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. TYPES OF IMMUNITY

2. TYPES OF IMMUNITY

38問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

7. PHAGOCYTOSIS Engulfment and Digestion

7. PHAGOCYTOSIS Engulfment and Digestion

21問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

8. PHAGOCYTOSIS EXOCYTOSIS

8. PHAGOCYTOSIS EXOCYTOSIS

15問 • 2年前

Yves Laure Pimentel · 32問 · 2年前

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

10. DISEASE ASSOCIATED TO HUMAN LEUKOCYTE ANTIGEN (henry)

32問 • 2年前

Yves Laure Pimentel · 30問 · 2年前

11. TRANSPLANTATION IMMUNOLOGY

11. TRANSPLANTATION IMMUNOLOGY

30問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. LYMPHOID ORGANS

2. LYMPHOID ORGANS

38問 • 2年前

Yves Laure Pimentel · 48問 · 2年前

3. CLUSTER OF DIFFERENTIATION

3. CLUSTER OF DIFFERENTIATION

48問 • 2年前

Yves Laure Pimentel · 35問 · 2年前

4. T-CELL DIFFERENTIATION

4. T-CELL DIFFERENTIATION

35問 • 2年前

Yves Laure Pimentel · 18問 · 2年前

5. T CELL IMMUNODEFICIENCIES

5. T CELL IMMUNODEFICIENCIES

18問 • 2年前

Yves Laure Pimentel · 44問 · 2年前

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

6. STAGES IN B-CELL DIFFERENTIATION  PROPIMAP

44問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

7. B CELL IMMUNODEFICIENCIES

7. B CELL IMMUNODEFICIENCIES

23問 • 2年前

Yves Laure Pimentel · 34問 · 2年前

8. COMBINED T CELL AND B CELL DEFICIENCIES

8. COMBINED T CELL AND B CELL DEFICIENCIES

34問 • 2年前

Yves Laure Pimentel · 12問 · 2年前

9. COMPARISON OF T AND B CELLS

9. COMPARISON OF T AND B CELLS

12問 • 2年前

Yves Laure Pimentel · 16問 · 2年前

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

10. LABORATORY IDENTIFICATION OF LYMPHOCYTES

16問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

11. NATURAL KILLER CELLS OR THIRD POPULATION CELL

15問 • 2年前

Yves Laure Pimentel · 79問 · 2年前

12. ANTIBODY

12. ANTIBODY

79問 • 2年前

Yves Laure Pimentel · 97問 · 2年前

13. TYPES OF ANTIBODIES

13. TYPES OF ANTIBODIES

97問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

14. MONOCLONAL ANTIBODIES

14. MONOCLONAL ANTIBODIES

11問 • 2年前

Yves Laure Pimentel · 23問 · 2年前

1. INTERLEUKINS

1. INTERLEUKINS

23問 • 2年前

Yves Laure Pimentel · 28問 · 2年前

2. INTERFERONS

2. INTERFERONS

28問 • 2年前

Yves Laure Pimentel · 8問 · 2年前

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

3. CYTOKINES IN THE INNATE AND ADAPTIVE IMMUNITY

8問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

4. COMPLEMENT SYSTEM

4. COMPLEMENT SYSTEM

19問 • 2年前

Yves Laure Pimentel · 76問 · 2年前

15. COMPLEMENT SYSTEM

15. COMPLEMENT SYSTEM

76問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

16. SYSTEM CONTROLS/COMPLEMENT REGULATION

21問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

17. COMPLEMENT AND DISEASE STATES

17. COMPLEMENT AND DISEASE STATES

29問 • 2年前

Yves Laure Pimentel · 19問 · 2年前

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

18. IMMUNOLOGIC ASSAYS OF INDIVIDUAL COMPONENTS (CLASSICAL)

19問 • 2年前

Yves Laure Pimentel · 22問 · 2年前

19. CYTOKINES

19. CYTOKINES

22問 • 2年前

Yves Laure Pimentel · 24問 · 2年前

20. INTERLEUKINS

20. INTERLEUKINS

24問 • 2年前

Yves Laure Pimentel · 21問 · 2年前

21. INTERFERONS, TNF, TGF, CHEMOKINE

21. INTERFERONS, TNF, TGF, CHEMOKINE

21問 • 2年前

Yves Laure Pimentel · 54問 · 2年前

1. SERO

1. SERO

54問 • 2年前

Yves Laure Pimentel · 38問 · 2年前

2. PRECIPITATION

2. PRECIPITATION

38問 • 2年前

Yves Laure Pimentel · 17問 · 2年前

3. PASSIVE IMMUNODIFFUSION

3. PASSIVE IMMUNODIFFUSION

17問 • 2年前

Yves Laure Pimentel · 15問 · 2年前

4. OUCHTERLONY

4. OUCHTERLONY

15問 • 2年前

Yves Laure Pimentel · 9問 · 2年前

5. ELECTROPHORETIC TECHNIQUE

5. ELECTROPHORETIC TECHNIQUE

9問 • 2年前

Yves Laure Pimentel · 11問 · 2年前

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

6. IMMUNOELECTROPHORESIS (DOUBLE DIFFUSION)

11問 • 2年前

Yves Laure Pimentel · 29問 · 2年前

7. IMMUNOFIXATION ELECTROPHORESIS

7. IMMUNOFIXATION ELECTROPHORESIS

29問 • 2年前